Missing/wrong data?
Log in to edit
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.
scientific article
Author/s
author: Kalijn Bol, Willeke A.M. Blokx, Wim Oyen, Carl Figdor, Jolanda de Vries, Gosse J Adema, Gerty Schreibelt
Work details
Publication date
February 10, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.